Subscribe to RSS - ResMed


ResMed highlights ‘positive’ tax changes


SAN DIEGO – Tax reform recently passed by Congress has “liberated our global cash assets to be able to be invested without artificial constraints,” ResMed CEO Mick Farrell said during a Jan. 22 conference call.

ATS, ResMed award $100,000 grant for vent research


SAN DIEGO – Dr. Jeremy Orr of the University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation in COPD. Dr.

Increased awareness buoys ResMed’s growth


SAN DIEGO – ResMed posted double-digit growth across the device and mask product categories for the second quarter of fiscal year 2018.

In brief: VA, HHS partner on fraud prevention; Beacon transitions HME biz to Alick’s


WASHINGTON – The U.S. Department of Veterans Affairs, the Department of Health and Human Services and CMS are partnering to strengthen fraud prevention efforts.

Study: ASV better for central apnea patients


SAN DIEGO – Patients with central sleep apnea who switch from positive airway pressure to adaptive servo ventilation therapy may be more adherent to therapy, according to a ResMed-funded study published in the Journal of Clinical Sleep Medicine.

ResMed boasts double-digit growth, with ‘more runway ahead’


SAN DIEGO – ResMed on Jan. 22 reported revenues of $601.3 million for the second quarter of fiscal year 2018, a 13% increased compared to the same quarter last year. Revenues in the U.S., Canada and Latin America, excluding Brightree, were $329.2 million, a 12% increase.

ResMed debuts Mobi


SAN FRANCISCO – ResMed has formally introduced its first portable oxygen concentrator to the market. The company says Mobi will be available to U.S. patients through their HME providers later this quarter, and it is pursuing clearance to sell in other countries in 2018.

Study: Hospitals can help diagnose sleep apnea


SAN DIEGO – A ResMed-funded study makes the case for hospitals screening patients for sleep apnea before they’re discharged to improve their chances of long-term survival.

ResMed named top corporate citizen


SAN DIEGO – ResMed has been named one of America’s top 100 corporate citizens for the second straight year by Forbes and JUST Capital, a nonprofit that analyzes and ranks companies based on how they serve the priorities of the American people. ResMed ranked No.

F&P files lawsuit in Australia


AUCKLAND, New Zealand – Fisher & Paykel Healthcare filed patent infringement proceedings against ResMed in the Federal Court of Australia on Dec.